Decision Modeling for Cost-Utility Analysis.

[1]  M. Sculpher.  Clinical trials provide essential evidence, but rarely offer a vehicle for cost-effectiveness analysis. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  Andrew Briggs,et al.  Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  J. Brazier,et al.  NICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values [Internet] , 2011 .

[4]  R. Willke,et al.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  Murray Krahn,et al.  Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.